MedCap AB (publ) (STO: MCAP)

Sweden flag Sweden · Delayed Price · Currency is SEK
376.50
-34.50 (-8.39%)
Jan 20, 2025, 5:29 PM CET
19.33%
Market Cap 5.57B
Revenue (ttm) 1.80B
Net Income (ttm) 228.00M
Shares Out 14.81M
EPS (ttm) 15.30
PE Ratio 24.61
Forward PE 22.66
Dividend n/a
Ex-Dividend Date n/a
Volume 302,055
Average Volume 57,234
Open 408.50
Previous Close 411.00
Day's Range 376.50 - 410.00
52-Week Range 316.00 - 632.00
Beta 0.70
RSI 16.99
Earnings Date Jan 31, 2025

About MedCap AB

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, pharmaceuticals, med tech and assistive tech companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Nordic region and Northern Europe. It typically invests between SEK25 millio... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2001
Employees 514
Stock Exchange Nasdaq Stockholm
Ticker Symbol MCAP
Full Company Profile

Financial Performance

In 2023, MedCap AB's revenue was 1.60 billion, an increase of 42.32% compared to the previous year's 1.12 billion. Earnings were 172.20 million, an increase of 46.43%.

Financial Statements

News

There is no news available yet.